Juniper Publishers: The Role of Lymphadenectomy in Patients with Endometrial Cancer
Journal of Gynecology and Women’s Health-Juniper
Publishers
Authored by Georgios Androutsopoulos
Editorial
Endometrial cancer (EC) represents the most common
malignancy of the female genital tract in developed countries [1-10].
Current international guidelines (ACOG, FIGO, SGO, ESGO and ESMO),
recommend systematic surgical staging as the initial treatment approach
for all types of EC [type I (endometrioid) and type II (serous, clear
cell, undifferentiated)] [2-4,6-15]. This is mainly because systematic
surgical staging offers many diagnostic, prognostic and therapeutic
benefits for these patients [2-4,6-13].
Pelvic and para-aortic lymphadenectomy represents an
integral part of the systematic surgical staging [2-4,6-11,16]. Pelvic
lymphadenectomy should include the remove of the nodal tissue from the
distal half of the common iliac artery, the external iliac artery and
vein (down to the deep circumflex iliac vein) and the obturator fat pad
(anterior to the obturator nerve) [11]. In para-aortic lymphadenectomy
the nodal tissue from the inferior vena cava and aorta (up to the level
of either the renal vessels or to the inferior mesenteric artery) is
dissected [8-11].
According to the revised FIGO staging system for
endometrial cancer, lymphadenectomy represents the only way to
accurately diagnose patients with FIGO stage IIIc disease
[2-4,6-13,16-18]. Therefore, lymphadenectomy provides important
information regarding the need for postoperative adjuvant treatment, in
order to maximize the survival and minimize the morbidity of
over-treatment (post-radiation effects, chemotherapy related toxicity)
and the risks of under-treatment (recurrence) [8,11,18-20].
The implementation of pelvic and para-aortic
lymphadenectomy in patients with early stage type I EC, does not affect
the overall and the disease free survival [2-11,13,21-23]. According to
the results of the ASTEC study, pelvic lymphadenectomy should not be
recommended as a routine procedure outside of clinical trials, in
patients with early stage type I EC [22]. However, this requires an
extensive intraoperative frozen section evaluation of the uterine
specimen, an approach usually not available or feasible in many
hospitals [11,20,22]. On the contrary, pelvic and para-aortic
lymphadenectomy improves overall survival in patients with advanced
stage type I EC as well as in all patients with type II EC [2-11,24-28].
There is an ongoing debate regarding the need and the
extent of para-aortic lymphadenectomy in EC patients, mainly because
the occurrence of isolated para-aortic lymph node metastases with
negative pelvic nodes, is approximately only 1-3,5% [8,11,20,29]. Based
on the results of the SEPAL study, combined pelvic and para-aortic
lymphadenectomy should be recommended in intermediate and high risk EC
patients (stage Ib or more in type I EC and any stage in type II EC), as
there are essential survival benefits [8,30]. Furthermore, the
implementation of para-aortic lymphadenectomy up to the level of renal
vessels is preferable, because most patients with para-aortic lymph node
involvement have metastases above the level of the inferior mesenteric
artery [8,29,31].
The extent of pelvic and para-aortic lymphadenectomy
should be confirmed pathologically in the tissue specimen [8,11].
Although there is not any limit regarding the number of the removed
lymph nodes, the removal of more than 10-12 lymph nodes is directly
correlated with improved prognosis [8,11,24,26,27,32]. Consequently, the
total number of the removed lymph nodes, reflects the adequacy of
lymphadenectomy [8,24,26].
The most common intraoperative and postoperative
complications of pelvic and para-aortic lymphadenectomy, are vessel or
nerve injury, pelvic lymphocysts, lymphoedema and cellulitis
[2-4,6,7,9-11,21,33,34]. Extended pelvic and paraaortic
lymphadenectomy (more than 14 lymph nodes) increases
significantly the risk for these perioperative complications
[2-4,6,7,9-11,21,33,34]. This is the main reason why, surgeons
should carefully balance the increased morbidity and the risk for
perioperative complications with any survival benefit, especially
in elderly patients and in patients with comorbidities (obesity,
diabetes mellitus and coronary artery disease) [2-4,6,7,9-
11,33,35,36].
In recent years, the sentinel lymph node detection and
dissection has emerged as an attractive approach, mainly because
it could potentially be related to reduced risk of perioperative
complications compared to the systematic lymphadenectomy.
Particularly in EC, sentinel lymph node dissection still remains
experimental and represents a balance between systematic
lymphadenectomy and no dissection in low and intermediate
risk EC patients [8,37-42]. The approach is based on the theory
that lymph drains away from the tumor in a specific centrifugal
pattern [38,39]. Consequently, if the sentinel lymph node is
negative for metastasis, then the chance that more distal nodes
are involved by tumor is very low, and therefore the need for
further lymphadenectomy is not necessary [38,39].
There are many arguments regarding the site of injection
(cervix, uterine serosa or endometrium), the injection method
and the used injected agent (99mTc, patent blue and indocyanine
green) [8,13,38,39,41,43-48]. Based on the results of the
SENTI-ENDO study, sentinel lymph node mapping could play
an essential role in the identification of lymph nodes with
micrometastases, especially in EC patients with early stage disease
[8,13,38,39,41,43,49,50]. Nevertheless, further prospective
randomized clinical trials are needed [8,37,39,40,50].
In conclusion, pelvic and para-aortic lymphadenectomy plays
an essential role in the systematic surgical staging of patients with
EC [2-4,6-11,16]. Moreover, provides important information for
the postoperative adjuvant treatment of these patients, in order
to maximize the survival and minimize the morbidity of overtreatment
(post-radiation effects, chemotherapy related toxicity)
and the risks of under-treatment (recurrence). Provisional
results of the sentinel lymph node dissection look promising
and future studies would be able to show if this approach could
replace the systematic lymphadenectomy.
For more open
access journals in JuniperPublishers please click on: https://juniperpublishers.com/
For more articles on Gynecology and Women’s
Health please click on: https://juniperpublishers.com/jgwh/
Comments
Post a Comment